/Investor DB

Gron Ventures, Llc — Full Portfolio

4 tracked investments · listed companies and verified rows first

Dutchiedutchie.comin𝕏Jan 2024 · $100M

Dutchie operates an online marketplace connecting consumers with cannabis dispensaries across North America, offering real-time menus, order-ahead pickup, and delivery.

E-commerceMarketplacesRetail Tech

Zach Lipson(Founder)inRoss Lipson(Founder)Ross Lipson Zach Lipson(Founder)

Co-investorsCasa Verde CapitalGlynn Capital ManagementJam FundLevel One FundSinai Capital PartnersTidemark+6 more

FLOWER CO.flowercompany.comin𝕏Series A

Flower Co. is a vertically integrated legal cannabis company that sells cannabis products online with next-day delivery across several California cities.

ConsumerDirect to ConsumerE-commerceMarketplacesLos Angeles, US

Scott Davies(Chief Strategy Officer (CSO))inTed Lichtenberger(Founder)inChad Powell(Vice President Product and Growth)inTony DiepenbrockTamara Leonard(Senior Technical Recruiter)

Co-investorsArtemis Growth PartnersFlying Tiger CapitalService Provider CapitalVU Venture PartnersY CombinatorAccess X+8 more

Gilgamesh Pharmaceuticalsgilgameshpharmaceutical.comin𝕏Series A · Dec 2022 · $39Macquired by AbbVie · Aug 2025 · $1.2B

Gilgamesh Pharmaceutical develops novel chemical entities for psychiatric disorders using medicinal chemistry and AI-powered translational platforms to design rapid-acting therapies targeting neurobiological mechanisms rather than symptom management.

AI & Machine LearningBiotechDigital HealthHealthtechNew York City, US

Jonathan Sporn(Founder)inAndrew Kruegel(Founder)inDalibor Sames(Founder)inAndrew Kruegel, Ph.D.(Executive Officer)Thomas Kevin Murphy, Ph.D.(Executive Officer)JONATHAN SPORN(Founder)in

Co-investorsAera VCAlumni VenturesAwareness VentureFrontera Technology VenturesFrontier Path VCGaingels+27 more

Rev Genomicsrevgenomics.cominSeries A · Apr 2019

Rev Genomics is a plant biotechnology company that develops novel plant cultivars.

AgTechBiotechDeep TechHealthtechMedical DevicesSan Francisco, US

Bertrand Vick(Founder/CEO)inRobert John Markelz(Executive Officer, Director, Promoter)Gloria E Webster(Director, Promoter)Robert Markelz(Vice President of Genomics)

Co-investorsY CombinatorMerida Capital HoldingsAdditionAgrolimen VenturesFloret VenturesL4 Inc.+3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.